Tiotropium in asthma: back to the future of anticholinergic treatment.

about

Tiotropium in asthma: back to the future of anticholinergic treatment.

Item

http://www.wikidata.org/entity/Q47164061

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tiotropium in asthma: back to the future of anticholinergic treatment.

@en

Tiotropium in asthma: back to the future of anticholinergic treatment.

@nl

type

Item

label

Tiotropium in asthma: back to the future of anticholinergic treatment.

@en

Tiotropium in asthma: back to the future of anticholinergic treatment.

@nl

prefLabel

Tiotropium in asthma: back to the future of anticholinergic treatment.

@en

Tiotropium in asthma: back to the future of anticholinergic treatment.

@nl

P1476

Tiotropium in asthma: back to the future of anticholinergic treatment

@en

P2093

Nicola Scichilone

http://www.w3.org/2001/XMLSchema#string

P2860

Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta 2 -agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma

Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study

The global burden of asthma: executive summary of the GINA Dissemination Committee report

Motor control of airway goblet cells and glands.

Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide.

A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.

Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma.

P2888

s12948-017-0076-1

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12948-017-0076-1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matteo Bonini

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092393380

http://www.w3.org/2001/XMLSchema#string

P698

29213218

http://www.w3.org/2001/XMLSchema#string

P921

asthma

P932

5713051

http://www.w3.org/2001/XMLSchema#string